USDA Boosts Food Safety Research with Purchase of Waters ACQUITY TQD System
February 27, 2009
UPLC/Tandem Quadrupole Mass Spectrometry System Intended for Veterinary Drug Residue Analysis of Poultry and Livestock MILFORD, Mass., Feb. 27 -- Waters Corporation (NYSE: WAT - News) announced today that the United States Department of Agriculture's Agricultural Research Service has purchased a Waters® ACQUITY® TQD System to develop rapid and accurate test methods for screening poultry [...]
Millipore Announces Technology Acquisition to Strengthen Drug Discovery Product Offering
February 26, 2009
BILLERICA, Mass.--Millipore Corporation (NYSE: MIL), a leading provider of technologies, tools and services for the global life science industry, today announced that it has purchased the assets associated with Epitome Biosystems’ EpiTag™ technology. The purchase price was not disclosed. The technology acquisition will enable Millipore’s Bioscience Division to expand its presence in the fast growing [...]
CombiMatrix Announces Positive Preliminary Data on Non-Invasive, Cancer Screening Test
February 26, 2009
Data Demonstrates that Test Can Identify Cancer Early Through Analysis of Blood MUKILTEO, Wash., Feb. 26, 2009 -- CombiMatrix Corporation (NasdaqGM:CBMX - News) today announced positive preliminary data on its investigational Comprehensive Cancer Array (CCA) test showing it can non-invasively screen for the early detection of cancer. The study focused on prostate, colon, ovarian, breast, [...]
Promega pmirGLO Brings New Capability for Study of microRNA Activity
February 26, 2009
MADISON, Wis.--Promega Corporation announces the availability of the new pmirGLO Dual-Luciferase miRNA Target Expression Vector. pmirGLO supports both breadth and depth in the microRNA study. Researchers have both ability to measure a wide dynamic range of miRNA activity in a vast number of cell types and the option to create a stable cell line from [...]
Jeffrey A. Komatz Named Chief Financial Officer of Protein Discovery, Inc.
February 26, 2009
KNOXVILLE, TN--(February 26, 2009) - Protein Discovery, Inc., a privately held life sciences company, today announced that it has hired Jeffrey A. Komatz for the position of chief financial officer. Mr. Komatz will be responsible for ensuring the continued financial health of Protein Discovery. As the CFO, Mr. Komatz will plan and manage the company's [...]
PSA Enters Into Business Alliance Agreement With Fisher Healthcare
February 26, 2009
FLORENCE, S.C., Feb. 26 -- Pathology Service Associates, LLC (PSA), a MED3OOO Company, the country's leading provider of revenue cycle management and other support services to independent pathologists across the United States, has entered into a Business Alliance Agreement with Fisher Healthcare, a part of Thermo Fisher Scientific, Inc. PSA's Business Alliance Program enables PSA-affiliated [...]
February 26, 2009
HERCULES, CA – February 26, 2009 – Bio-Rad Laboratories, Inc, (NYSE: BIO and BIOb), a multinational manufacturer and distributor of life science research and clinical diagnostic products, today announced the company, Novartis Institutes for BioMedical Research and Nonlinear Dynamics are coordinating the proteomics community's efforts to develop standards and validated protocols that will ensure reproducibility [...]
Helixis Appoints Illumina CEO Jay Flatley to Board of Directors
February 26, 2009
CARLSBAD, Calif.--Helixis, Inc., developer of nucleic acid analysis tools, announced today that Jay Flatley, CEO of Illumina, Inc., has joined the company’s board of directors. Under Flatley’s leadership Illumina has become the market leader in genotyping and next-generation sequencing systems, and has completed numerous strategic technology acquisitions. Recognizing the company’s record of growth, Forbes magazine [...]
BioTime’s Subsidiary Enters Agreement Adding New Embryonic Stem Cell Lines to Its Product Portfolio
February 26, 2009
BioTime, Inc., (OTCBB:BTIM) announced today that its wholly-owned subsidiary Embryome Sciences, Inc. has entered into an agreement with Reproductive Genetics Institute (RGI) of Chicago, Illinois granting Embryome Sciences rights to market new human embryonic stem cell (hES) lines selected by Embryome Sciences from 294 hES lines derived by RGI. Embryome Sciences will initially select 10 [...]
February 26, 2009
MADISON, Wis.--The NMD-Chip Consortium, an initiative of the Seventh Framework Programme for Research and Technological Development, recently selected Roche NimbleGen microarrays to accelerate and simplify genetic research of neuromuscular disorders (NMDs). The NMD-Chip Consortium is comprised of 13 European entities from eight countries whose goal is to further our understanding of NMDs and to investigate [...]
